Brief

The Commission Implementing Regulation (EU) 2024/2563 amends Implementing Regulation (EU) 2022/1646 to update national risk-based control plans and national randomised surveillance plans. This regulation clarifies the submission of these plans, data by Member States, and minimum sampling frequencies, ensuring consistency with existing regulations. This amendment affects the national control programs for pharmacologically active substances, requiring Member States to specify the species to be sampled and competent authorities responsible for implementation. It also eliminates double reporting and ensures compliance with Annex I's additional provisions on minimum sampling frequencies.

This content is restricted.

Highlights content goes here...

This content is restricted.

Register of Delegated and Implementing Acts

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies